Your browser doesn't support javascript.
loading
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease.
Ruscitti, Piero; Natoli, Valentina; Consolaro, Alessandro; Caorsi, Roberta; Rosina, Silvia; Giancane, Gabriella; Naddei, Roberta; Di Cola, Ilenia; Di Muzio, Claudia; Berardicurti, Onorina; Iacono, Daniela; Pantano, Ilenia; Rozza, Gelsomina; Rossi, Silvia; De Stefano, Ludovico; Balduzzi, Silvia; Vitale, Antonio; Caso, Francesco; Costa, Luisa; Prete, Marcella; Navarini, Luca; Iagnocco, Annamaria; Atzeni, Fabiola; Guggino, Giuliana; Perosa, Federico; Cantarini, Luca; Frediani, Bruno; Montecucco, Carlomaurizio; Ciccia, Francesco; Cipriani, Paola; Gattorno, Marco; Giacomelli, Roberto; Ravelli, Angelo.
Affiliation
  • Ruscitti P; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila.
  • Natoli V; Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università degli Studi di Genova, Genoa.
  • Consolaro A; Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università degli Studi di Genova, Genoa.
  • Caorsi R; UOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa.
  • Rosina S; UOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa.
  • Giancane G; UOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa.
  • Naddei R; Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università degli Studi di Genova, Genoa.
  • Di Cola I; UOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa.
  • Di Muzio C; UOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa.
  • Berardicurti O; Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II.
  • Iacono D; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila.
  • Pantano I; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila.
  • Rozza G; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila.
  • Rossi S; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples.
  • De Stefano L; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples.
  • Balduzzi S; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples.
  • Vitale A; Rheumatology Department, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia.
  • Caso F; Rheumatology Department, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia.
  • Costa L; Rheumatology Department, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia.
  • Prete M; Research Center of Systemic Auto Inflammatory Diseases, Behçet's Disease and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, Policlinico 'Le Scotte', University of Siena, Siena.
  • Navarini L; Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples.
  • Iagnocco A; Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples.
  • Atzeni F; Rheumatic and Systemic Autoimmune Diseases Unit, Department of Biomedical Science and Human Oncology (DIMO), University of Bari Medical School, Bari.
  • Guggino G; Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome.
  • Perosa F; Academic Rheumatology Centre, Ospedale Mauriziano - Dipartimento Scienze Cliniche e Biologiche, Università degli Studi di Torino, Turin.
  • Cantarini L; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina.
  • Frediani B; Rheumatology Section, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University Hospital 'P. Giaccone', Palermo.
  • Montecucco C; Rheumatic and Systemic Autoimmune Diseases Unit, Department of Biomedical Science and Human Oncology (DIMO), University of Bari Medical School, Bari.
  • Ciccia F; Research Center of Systemic Auto Inflammatory Diseases, Behçet's Disease and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, Policlinico 'Le Scotte', University of Siena, Siena.
  • Cipriani P; Research Center of Systemic Auto Inflammatory Diseases, Behçet's Disease and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, Rheumatology Unit, Policlinico 'Le Scotte', University of Siena, Siena.
  • Gattorno M; Rheumatology Department, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia.
  • Giacomelli R; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Naples.
  • Ravelli A; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila.
Rheumatology (Oxford) ; 61(10): 4124-4129, 2022 10 06.
Article in En | MEDLINE | ID: mdl-35078234
ABSTRACT

OBJECTIVE:

To compare clinical features and treatments of patients with systemic JIA (sIJA) and adult-onset Still's disease (AOSD).

METHODS:

The clinical charts of consecutive patients with sJIA by International League of Association of Rheumatology criteria or AOSD by Yamaguchi criteria were reviewed. Patients were seen at a large paediatric rheumatology referral centre or at 10 adult rheumatology academic centres. Data collected included clinical manifestations, inflammation biomarkers, systemic score, macrophage activation syndrome (MAS), parenchymal lung disease, disease course, disability, death and medications administered.

RESULTS:

A total of 166 patients (median age at diagnosis 5 years) with sJIA and 194 patients with AOSD (median age at diagnosis 41 years) were included. The frequency of fever, rash, arthralgia, abdominal pain, MAS, parenchymal lung disease and increased acute phase reactants and ferritin were comparable between the two cohorts. Patients with sJIA had a higher prevalence of arthritis, whereas patients with AOSD had experienced leucocytosis and extra-articular organ involvement more frequently. Patients with AOSD were given more commonly low-dose corticosteroids, whereas biologic DMARDs were administered first-line more frequently in patients with sJIA.

CONCLUSION:

We found remarkable disparities in the prevalence of clinical manifestations between the two illnesses, which may partly depend on their classification by different criteria.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile / Biological Products / Still's Disease, Adult-Onset / Antirheumatic Agents / Macrophage Activation Syndrome / Lung Diseases Type of study: Diagnostic_studies / Etiology_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Child / Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile / Biological Products / Still's Disease, Adult-Onset / Antirheumatic Agents / Macrophage Activation Syndrome / Lung Diseases Type of study: Diagnostic_studies / Etiology_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Child / Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Document type: Article